Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 3 TRIUMPH-4 results (December 2025): The 12mg once-weekly dose achieved 28.7% mean body weight loss over 68 weeks
What a Pre-Mixed Reta+Cagri COA Should Include Identity confirmation (both compounds) Mass spectrometry showing two distinct peaks at the expected molecular weights: Retatrutide: ~4731 Da Cagrilintide: ~3775 Da HPLC chromatogram showing two well-resolved peaks at the expected retention times Purity testing (both compounds) HPLC purity for retatrutide: 97%+ (research-grade floor) HPLC purity for cagrilintide: 97%+ (research-grade floor) Each compound assessed independently not a single combined purity number Ratio quantification Reported as the actual mass ratio in the vial (e.g., "12.4 mg retatrutide : 2.6 mg cagrilintide" or "83% retatrutide / 17% cagrilintide by mass") Match to the labeled ratio (5:1 = 83.3% / 16.7%) Contamination testing Bacterial endotoxin Heavy metals Residual solvents Red Flags Specific to Pre-Mixed Blends COA reports a single purity number without breaking it down per compound
Blend examined for complementary pathways enhancing GH secretion profiles in laboratory settings
Rather than a series of short spikes, the long-acting form keeps a gentle, ongoing prompt in place
US$ 20.57
US$ 23.00
US$ 24.82
US$ 23.15
US$ 20.90
US$ 21.59
US$ 25.45
US$ 24.01
US$ 21.74
US$ 24.35
